Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer—A randomized controlled trial of alpha-1 adrenoceptor antagonist alone versus combination with cyclooxygenase-2 inhibitor—

Dose Rate ◽

Low Dose ◽

Controlled Trial ◽

Urinary Function ◽

Adrenoceptor Antagonist ◽

Low Dose Rate ◽

Randomized Controlled ◽

Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of alpha-1 adrenoceptor antagonist alone vs. combination with cyclooxygenase-2 inhibitor

European Urology Supplements ◽

10.1016/s1569-9056(18)31979-1 ◽

2018 ◽

Vol 17 (2) ◽

pp. e1635-e1636

Author(s):

N. Tanaka ◽

K. Torimoto ◽

I. Asakawa ◽

M. Miyake ◽

S. Anai ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Low Dose ◽

Controlled Trial ◽

Urinary Function ◽

Adrenoceptor Antagonist ◽

Low Dose Rate ◽

Randomized Controlled ◽

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Radiation Oncology ◽

10.1186/s13014-014-0302-7 ◽

2014 ◽

Vol 9 (1) ◽

Cited By ~ 8

Author(s):

Nobumichi Tanaka ◽

Kazumasa Torimoto ◽

Isao Asakawa ◽

Makito Miyake ◽

Satoshi Anai ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Low Dose ◽

Controlled Trial ◽

Low Dose Rate ◽

Randomized Controlled ◽

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

Journal of Contemporary Brachytherapy ◽

10.5114/jcb.2019.88142 ◽

2019 ◽

Vol 11 (5) ◽

pp. 409-416 ◽

Cited By ~ 1

Author(s):

Yasushi Nakai ◽

Nobumichi Tanaka ◽

Isao Asakawa ◽

Kazumasa Torimoto ◽

Makito Miyake ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Low Dose ◽

Controlled Trial ◽

Adrenoceptor Antagonist ◽

Low Dose Rate ◽

Randomized Controlled ◽

Editorial Comment to Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil

International Journal of Urology ◽

10.1111/iju.14690 ◽

2021 ◽

Author(s):

Yoshifumi Kadono

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Low Dose ◽

Controlled Trial ◽

Low Dose Rate ◽

Randomized Controlled ◽

Disease Specific ◽

Results of a Phase I Randomized-Controlled Trial Evaluating Conventional vs. Machine Learning Treatment Planning for Prostate Low-Dose-Rate Brachytherapy

Brachytherapy ◽

10.1016/j.brachy.2018.04.095 ◽

2018 ◽

Vol 17 (4) ◽

pp. S59-S60

Author(s):

Alexandru M. Nicolae ◽

Mark Semple ◽

Lin Lu ◽

Mackenzie Smith ◽

Hans T. Chung ◽

...

Keyword(s):

Machine Learning ◽

Phase I ◽

Dose Rate ◽

Treatment Planning ◽

Low Dose ◽

Controlled Trial ◽

Low Dose Rate ◽

Randomized Controlled ◽

Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil

International Journal of Urology ◽

10.1111/iju.14667 ◽

2021 ◽

Author(s):

Fumisato Maesaka ◽

Nobumichi Tanaka ◽

Yasushi Nakai ◽

Isao Asakawa ◽

Mitsuru Tomizawa ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Low Dose ◽

Controlled Trial ◽

Low Dose Rate ◽

Randomized Controlled ◽

Disease Specific ◽

413 Permanent interstitial low-dose rate brachytherapy for patients with localized prostate cancer – a systematic review of randomized and non-randomized controlled clinical trials

European Urology Supplements ◽

10.1016/s1569-9056(12)60410-2 ◽

2012 ◽

Vol 11 (1) ◽

pp. e413-e413a

Author(s):

F. Peinemann ◽

U. Grouven ◽

C. Bartel ◽

S. Sauerland ◽

H. Borchers ◽

...

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Clinical Trials ◽

Dose Rate ◽

Low Dose ◽

Controlled Clinical Trials ◽

Randomized Controlled Clinical Trials ◽

Low Dose Rate ◽

Randomized Controlled ◽

Phase I, Randomized-Controlled Trial of Conventional versus Machine Learning Based Treatment Planning for Low Dose Rate (LDR) Prostate Brachytherapy

Brachytherapy ◽

10.1016/j.brachy.2019.04.133 ◽

2019 ◽

Vol 18 (3) ◽

pp. S63

Author(s):

Alexandru M. Nicolae ◽

Mark Semple ◽

Lin Lu ◽

Mackenzie Smith ◽

Hans Chung ◽

...

Keyword(s):

Machine Learning ◽

Phase I ◽

Dose Rate ◽

Treatment Planning ◽

Low Dose ◽

Controlled Trial ◽

Prostate Brachytherapy ◽

Low Dose Rate ◽

Randomized Controlled

Low-dose rate brachytherapy for patients with low or intermediate-risk prostate cancer. Analysis of relapse-free survival

Experimental and Сlinical Urology ◽

10.29188/2222-8543-2019-11-2-44-49 ◽

2019 ◽

Vol 11 (2) ◽

pp. 44-49

Author(s):

V.A. Solodky ◽

◽

A.Yu. Pavlov ◽

A.D. Tsybulskiy ◽

A.S. Pchelintsev ◽

...

Keyword(s):

Prostate Cancer ◽

Dose Rate ◽

Low Dose ◽

Intermediate Risk ◽

Relapse Free Survival ◽

Free Survival ◽

Low Dose Rate ◽

Risk Prostate Cancer ◽

Longitudinal Changes in Health-related Quality of Life After 125I Low-dose-rate Brachytherapy for Localized Prostate Cancer

Anticancer Research ◽

10.21873/anticanres.14666 ◽

2020 ◽

Vol 40 (11) ◽

pp. 6443-6456

Author(s):

NAOYUKI OGASAWARA ◽

MAKOTO NAKIRI ◽

HIROFUMI KUROSE ◽

KOSUKE UEDA ◽

KATSUAKI CHIKUI ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Dose Rate ◽

Low Dose ◽

Health Related Quality ◽

Low Dose Rate ◽

Related Quality ◽

Health Related ◽